ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Biejiajian Pill Promotes the Infiltration of CD8+ T Cells in Hepatocellular Carcinoma by Regulating the Expression of CCL5

Yang, Xuemei; Sun, Jialing; Wen, Bin; Wang, Yu; Zhang, Mingjia; Chen, Weicong; Zhao, Wenting; He, Chunyu; Zhong, Xiaodan; Liu, Yang; Li, Tong; Sun, Haitao*; He, Songqi*南方医科大学
Frontiers in Pharmacology2021-11-26DOI: 10.3389/fphar.2021.771046
4被引5阅读
引用收藏
分享

摘要

Tumor-infiltrating CD8(+)T lymphocytes are mostly associated with a favorable prognosis in numerous cancers, including hepatocellular carcinoma (HCC). Biejiajian Pill (BJJP) is a common type of traditional Chinese medicine that is widely used in the treatment of HCC in China. Previous studies showed that BJJP suppressed the growth of HCC cells both in vivo and in vitro, by exerting direct cytotoxic effects on tumor cells. The present study demonstrated that in addition to direct cytotoxicity, BJJP inhibits the growth of tumor cells by promoting the infiltration of CD8(+)T cells into the tumor in H-22-bearing mice. Mechanistically, chemokine ligand 5 (CCL5) was identified as one of the most highly expressed chemokines by tumor cells in vivo after treatment with BJJP. Additionally, CCL5 was knocked down in H-22 cells and the results showed that knockdown of the gene significantly impaired the infiltration of CD8(+)T cells in vivo. Furthermore, the effects of BJJP on human HCC cell lines were assessed in vitro. Similarly, cells treated with BJJP had higher expression of CCL5 mRNA, which was consistent with increased levels of CCL5 protein in human tumor cells. These findings provide new insights into the anticancer effects of BJJP, which regulated the expression of CCL5 and the infiltration of CD8(+)T cells. The results, therefore, suggest that BJJP has great potential application in clinical practice.

学科与关键词

关键词
hepatocellular carcinomatraditinal Chinese medicineCD8(+)T cellCCL5Biejiajian Pill
相关
加载中…
  • Biejiajian Pill Inhibits Carcinogenesis and Metastasis via the Akt/GSK-3β/Snail Signaling Pathway in Hepatocellular Carcinoma
    Sun, Jialing; Chen, Weicong; Wen, Bin; Zhang, Mingjia; Sun, Haitao; Yang, Xuemei; Zhao, Wenting; La, Lei; An, Haiyan; Pang, Jie; Gao, Lei*; He, Songqi*Frontiers in Pharmacology, 2021, 12: 610158.被引 8
  • Biejiajian pill inhibits progression of hepatocellular carcinoma by downregulating PDGFRO signaling in cancer-associated fibroblasts
    Chen, Weicong; Yang, Xuemei; Sun, Jialing; Chen, Yuyao; Zhao, Wenting; He, Chunyu; An, Haiyan; Pang, Jie; Xu, Wei; Wen, Bin*; Sun, Haitao*; He, Songqi*Journal of Ethnopharmacology, 2023, 301: 115825.被引 1
  • Jianpi Huayu Decoction Attenuates the Immunosuppressive Status of H22 Hepatocellular Carcinoma-Bearing Mice: By Targeting Myeloid-Derived Suppressor Cells
    Xie, Yingjie; Zhang, Yuan; Wei, Xiaohan; Zhou, Cheng; Huang, Yajing; Zhu, Xingwang; Chen, Yongxu; Wen, Huihong; Huang, Xuhui; Lin, Juze; Wang, Ziying; Ren, Yan; Fan, Baochao; Deng, Xue; Tan, Wei*; Wang, Changjun*Frontiers in Pharmacology, 2020, 11: 16.被引 20
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Pharmacology
发表日期
2021-11-26
卷期
第 12 卷
页码
771046
DOI
10.3389/fphar.2021.771046
语言
ENGLISH
期刊收录
NSL
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81573808, 81774037, 82004077]; Natural Science Foundation of Guangdong Province [2021A1515012591, 2019A1515110062]; Project of Administration of Traditional Chinese Medicine of Guangdong Province of China [20201223]

作者

  • Y

    Yang, Xuemei (第一作者)

    southern med univ

  • S

    Sun, Jialing

    southern med univ

查看全部 13 位作者收起作者
  • W

    Wen, Bin

  • W

    Wang, Yu

    southern med univ

  • Z

    Zhang, Mingjia

    southern med univ

  • C

    Chen, Weicong

    southern med univ

  • Z

    Zhao, Wenting

    southern med univ

  • H

    He, Chunyu

    southern med univ

  • Z

    Zhong, Xiaodan

    southern med univ

  • L

    Liu, Yang

    southern med univ

  • L

    Li, Tong

    southern med univ

  • S

    Sun, Haitao (通讯)

    southern med univ

  • H

    He, Songqi (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417